Immunotherapy for Prostate Cancer: Types, Side Effects & More

Prostate cancer affects a significant number of men worldwide, accounting for 21% of all cancer cases and causing around 345,000 deaths each year. To improve prostate cancer care, researchers are urgently looking into new treatments. They looked at four trials involving nearly 3,600 participants who received different types of immunotherapy, such as DCVAC, ipilimumab, personalized peptide vaccine, and the PROSTVAC vaccine. The results, particularly for ipilimumab, showed promising trends in improving overall survival.

Additionally, the researchers found 68 ongoing trials involving over 7,900 participants, with data expected to be collected until June 2028. Immunotherapy, especially using immune checkpoint inhibitors and adjuvant therapies, is emerging as a potential treatment option for prostate cancer. Ongoing trials will provide further insights into how these therapies can improve outcomes for patients in the future.

What is Prostate Cancer? 

Prostate cancer is a type of cancer that occurs in the prostate gland, which is a small walnut-shaped gland in men that produces seminal fluid, the fluid that nourishes and transports sperm. Prostate cancer is one of the most common types of cancer in men.

Normally, prostate cancer grows slowly and initially remains confined to the prostate gland, where it may not cause serious harm. However, some types of prostate cancer can be aggressive and spread quickly beyond the prostate, leading to more serious health problems.

Symptoms of prostate cancer may include:

  • Trouble urinating
  • Decreased force in the stream of urine
  • Blood in semen
  • Discomfort in the pelvic area
  • Bone pain
  • Erectile dysfunction

However, in its early stages, prostate cancer may not cause any symptoms. This is why routine screenings, such as the prostate-specific antigen (PSA) blood test and digital rectal exam (DRE), are important for early detection.

Types of Prostate Cancer

Prostate cancer can be classified into different types based on various factors such as the microscopic appearance of cancer cells, how quickly the cancer is likely to grow and spread, and the presence of specific genetic mutations. Here are some common types of prostate cancer:

Adenocarcinoma: Adenocarcinoma is the most common type of prostate cancer, accounting for the vast majority of cases. It arises from the glandular cells of the prostate and typically grows slowly.

Small Cell Carcinoma: Small cell carcinoma of the prostate is a rare and aggressive type of prostate cancer. It tends to grow and spread more rapidly than adenocarcinoma and may require different treatment approaches.

Ductal Carcinoma: Ductal carcinoma of the prostate is another rare subtype characterized by the growth of cancer cells within the ducts of the prostate gland. It can be more aggressive than adenocarcinoma and may have a poorer prognosis.

Transitional Cell Carcinoma: Transitional cell carcinoma, also known as urothelial carcinoma, can occur in the prostate but is more commonly found in the bladder. It arises from the cells lining the urinary tract and may require different treatment approaches than adenocarcinoma.

Prostatic Sarcoma: Prostatic sarcoma is a rare type of prostate cancer that develops in the connective tissue of the prostate gland. It is typically more aggressive than adenocarcinoma and may have a poorer prognosis.

Neuroendocrine Tumors: Neuroendocrine tumors of the prostate are rare and aggressive cancers that can develop from neuroendocrine cells within the prostate gland. They may behave differently from adenocarcinoma and often require specialized treatment.

Metastatic Prostate Cancer: Metastatic prostate cancer refers to cancer that has spread from the prostate to other parts of the body, such as the bones, lymph nodes, or other organs. It can be adenocarcinoma or another subtype that has metastasized.

These are just some of the types of prostate cancer that can occur, and each may require different treatment approaches based on factors such as the stage of the cancer, its aggressiveness, and the overall health of the patient. It’s important for individuals diagnosed with prostate cancer to work closely with their healthcare team to determine the most appropriate treatment plan for their specific situation.

What Is Immunotherapy?

Immunotherapy is a type of treatment that helps your body’s own immune system fight diseases like cancer. Normally, your immune system protects you by attacking harmful things like bacteria and viruses. But sometimes, it doesn’t recognize cancer cells as a threat. Immunotherapy works by boosting your immune system’s ability to recognize and destroy cancer cells. 

It’s like giving your body’s defense system a power-up to better fight against cancer. This treatment can come in different forms, like drugs or vaccines, and it’s becoming an important tool in the fight against cancer.

Benefits of Immunotherapy

Here are some of the major benefits of immunotherapy:

Targeted Treatment: Immunotherapy specifically targets cancer cells while sparing healthy cells, reducing the risk of side effects commonly associated with traditional treatments like chemotherapy and radiation therapy.

Enhanced Immune Response: Immunotherapy boosts the body’s natural immune response, empowering it to recognize and attack cancer cells more effectively.=

Long-lasting Effects: In some cases, immunotherapy can lead to durable responses, meaning that the immune system continues to combat cancer cells even after the completion of treatment.

Treatment Versatility: Immunotherapy can be used as a standalone treatment or in combination with other therapies, providing flexibility in treatment approaches and potentially improving outcomes for patients.

Improved Quality of Life: With fewer side effects compared to conventional treatments, immunotherapy can help maintain or even improve patients’ quality of life during and after treatment.

Potential for Personalization: Immunotherapy treatments can be tailored to individual patients based on factors such as their immune profile and genetic makeup, maximizing treatment effectiveness.

Hope for Advanced Cancers: Immunotherapy offers a promising treatment option for patients with advanced or metastatic cancers who may have limited treatment options, providing them with renewed hope and the potential for extended survival.

Why Choose Immunotherapy For Prostate Cancer?

Immunotherapy has emerged as a promising treatment option for prostate cancer due to its ability to harness the body’s own immune system to target and destroy cancer cells. Unlike traditional treatments like surgery, radiation, or chemotherapy, which directly target cancer cells, immunotherapy works by enhancing the body’s natural defenses against cancer.

One approach to immunotherapy involves the use of checkpoint inhibitors, which are drugs that release the brakes on the immune system, allowing it to recognize and attack cancer cells more effectively. Another approach is to develop vaccines that stimulate the immune system to recognize and target prostate cancer cells specifically.

Immunotherapy has shown remarkable efficacy in certain subsets of prostate cancer patients. For example, in men with advanced-stage hormone-resistant prostate cancer, immunotherapy has demonstrated significant benefits, including improved survival rates and enhanced quality of life. By unleashing the immune system to attack the cancer, immunotherapy can help control the progression of the disease and prolong life expectancy.

Moreover, when combined with standard treatments like hormone therapy, immunotherapy has been shown to reduce the risk of cancer recurrence in men with high-risk, localized tumors. This combination approach can enhance the effectiveness of treatment and improve long-term outcomes for patients.

While immunotherapy holds great promise, it’s important to note that not all prostate cancer patients will benefit from this treatment. The effectiveness of immunotherapy can vary depending on factors such as the specific characteristics of the tumor, the patient’s overall health, and their response to treatment.

Advancing Prostate Cancer Care with Personalized Immunotherapy Treatments

The immune system is our body’s natural defense mechanism against harmful invaders like viruses, bacteria, and even cancer cells. However, in many cancer patients, the immune system doesn’t recognize the cancer cells as threats or may be suppressed by the cancer itself. Immunotherapy is a revolutionary approach that aims to harness the power of the immune system to fight cancer.

  • One type of immunotherapy used for prostate cancer is Sipuleucel-T, also known as Provenge®. It’s a personalized vaccine made from a patient’s own immune cells. The process involves collecting immune cells from the patient, then stimulating them in a lab to recognize and attack prostate cancer cells. These activated immune cells are then infused back into the patient. While Sipuleucel-T doesn’t directly lower PSA levels or shrink tumors, it has been shown to prolong life in men with metastatic prostate cancer that is resistant to hormone therapy.
  • Another immunotherapy drug, Pembrolizumab, belongs to a class called immune checkpoint inhibitors. These drugs work by releasing the brakes on the immune system, allowing it to recognize and attack cancer cells more effectively. Pembrolizumab was approved for use in prostate cancer patients who have specific genetic mutations (MMR deficiency and/or MSI) and have progressed on other treatments. This drug is administered intravenously every three weeks.

While these immunotherapy treatments offer hope for prostate cancer patients, they can come with side effects. For Sipuleucel-T, common side effects include flu-like symptoms such as fever, chills, and muscle aches. Pembrolizumab may cause fatigue, cough, nausea, rash, and other symptoms. Additionally, there can be rare but serious side effects related to overactive immune responses, which may require stopping the treatment and using steroid medications to suppress the immune reactions.

It’s important for patients to discuss with their doctors whether immunotherapy is appropriate for them, considering factors like the stage and characteristics of their cancer, as well as their overall health and treatment goals. Ongoing research is continually improving our understanding of how immunotherapy can be used effectively in prostate cancer treatment.

Checkpoint Inhibitors For Prostate Cancer

The immune system possesses a remarkable ability to distinguish between normal cells and potentially harmful invaders, such as pathogens or cancer cells. One way it accomplishes this is through the use of “checkpoint” proteins, which act as switches that regulate immune responses. These checkpoints serve as crucial checkpoints to prevent the immune system from attacking the body’s own healthy cells.

However, cancer cells can exploit these checkpoints to evade detection and destruction by the immune system. They may activate these checkpoint proteins to suppress immune responses directed against them, allowing the cancer cells to proliferate and spread unchecked. This evasion mechanism poses a significant challenge for the immune system in effectively targeting and eliminating cancer cells.

Checkpoint inhibitors represent a revolutionary class of cancer treatments designed to counteract this immune evasion strategy employed by cancer cells. These drugs work by blocking the activity of checkpoint proteins on immune cells, thereby releasing the brakes on the immune response and unleashing its full potential to recognize and attack cancer cells.

Two notable checkpoint inhibitors, pembrolizumab and dostarlimab, target a checkpoint protein called PD-1, which is expressed on immune cells known as T cells. By inhibiting PD-1, these drugs effectively enhance the activity of T cells, boosting the immune response against cancer cells.

While checkpoint inhibitors like pembrolizumab and dostarlimab hold great promise as cancer treatments, their application in treating advanced prostate cancer is relatively rare. However, they may be considered as treatment options for certain subsets of patients with advanced prostate cancer who exhibit specific genetic alterations or biomarkers indicative of an increased likelihood of response to these drugs.

For instance, pembrolizumab may be prescribed for patients whose prostate cancer cells display a high level of microsatellite instability (MSI-H) or a defect in a mismatch repair gene (dMMR). Additionally, pembrolizumab may be considered for patients with a high tumor mutational burden (TMB-H), indicating a greater number of gene mutations within the cancer cells. Similarly, dostarlimab may be used in patients with prostate cancer cells harboring a defect in a mismatch repair gene (dMMR).

Despite the potential benefits of checkpoint inhibitors, it’s important to note that these genetic alterations are relatively uncommon in prostate cancer. However, for the subset of patients whose cancer cells exhibit these specific changes, treatment with pembrolizumab or dostarlimab may offer therapeutic benefits.

These checkpoint inhibitors are administered intravenously (IV) as infusions, typically every 3 to 6 weeks, under the supervision of healthcare professionals. Additionally, ongoing research efforts are focused on investigating the efficacy of checkpoint inhibitors in combination with other types of medicines, such as chemotherapy, hormonal therapy, or targeted therapy, to enhance treatment outcomes for patients with prostate cancer.

In summary, checkpoint inhibitors represent a promising avenue for the treatment of advanced prostate cancer, particularly in patients with specific genetic alterations associated with increased responsiveness to these drugs. Continued research and clinical trials will further elucidate the role of checkpoint inhibitors in prostate cancer treatment and their potential to improve patient outcomes.

Understanding the Immunotherapy Procedure for Prostate Cancer

Immunotherapy is typically conducted on an outpatient basis, meaning patients do not need to be admitted to a hospital for the procedure. The specific steps involved in the procedure may vary depending on the type of immunotherapy being administered.

For prostate cancer vaccines, the process begins with the patient being connected to a machine that removes white blood cells from their body over a period of a few hours. These white blood cells are then transported to a laboratory where they are combined with prostate-specific antigen (PAP) proteins. This combination is then reintroduced into the patient’s body through intravenous (IV) infusions. This method aims to stimulate the patient’s immune system to recognize and attack prostate cancer cells more effectively.

On the other hand, immunomodulator treatments for prostate cancer involve the administration of specific drugs via IV infusions. During the treatment session, a healthcare professional inserts a needle into a vein to deliver the medication directly into the bloodstream. These drugs are designed to modulate or enhance the body’s immune response against cancer cells.

The frequency of immunotherapy sessions varies depending on the specific treatment protocol. Immunomodulator treatments are typically repeated every 2 to 3 weeks, allowing for the medication to have a sustained effect on the immune system’s activity against cancer cells. In the case of prostate cancer vaccines, patients usually undergo a total of three treatments, spaced two weeks apart. This schedule aims to optimize the immune response generated by the vaccine over a series of treatments.

Throughout the immunotherapy process, patients are closely monitored by healthcare professionals for any potential side effects or adverse reactions. While immunotherapy offers promising benefits in treating prostate cancer, it’s important for patients to have a thorough understanding of the procedure and its potential outcomes before proceeding with treatment. Open communication with healthcare providers can help ensure that patients receive personalized care tailored to their specific needs and preferences.

Success Rate of Immunotherapy for Prostate Cancer

The success rate of immunotherapy for prostate cancer tends to be less substantial compared to its effectiveness in treating other types of cancer. Despite ongoing research efforts, the reasons behind this discrepancy remain unclear. However, it’s worth noting that while immunotherapy may not yield significant benefits for all prostate cancer patients, some individuals do experience positive outcomes with this treatment approach. 

Factors such as the specific characteristics of the tumor, the patient’s overall health, and their response to treatment can influence the effectiveness of immunotherapy. As research in this field continues to advance, there remains hope for further improvements in the success rate of immunotherapy for prostate cancer, potentially offering new avenues for treatment and better outcomes for patients.

Immunotherapy Side-Effects of Prostate Cancer

Immunotherapy, while effective in cancer treatment, can cause various side effects.

  • Common side effects include skin reactions such as pain, redness, swelling, rash, and itchiness.
  • Patients may also experience flu-like symptoms such as fever, nausea, and muscle aches.
  • Other potential side effects include joint pain, sinus congestion, cough, headache, and fatigue.
  • Additional side effects may involve fluid retention, reduced appetite, diarrhea or constipation, high blood pressure, and heart palpitations.
  • In rare cases, immunotherapy can lead to severe inflammation or allergic reactions.
  • Doctors may prescribe steroids to suppress the overactivity of the immune system in such instances.

Patients should remain vigilant for any signs of side effects and promptly report them to their healthcare providers for appropriate management.

Denvax: A Personalized Approach to Prostate Cancer Treatment

Denvax offers a revolutionary approach to combating prostate cancer by harnessing the power of a patient’s own immune system. This innovative treatment involves transforming a patient’s mononuclear cells into potent “cancer-fighting” dendritic cells.

Denvax is a form of dendritic cell-based cancer immunotherapy, utilizing these specialized immune cells to enhance the body’s ability to recognize and target cancer cells. Dendritic cells play a crucial role in immune recognition, a process often impaired in cancer patients.

As an adjuvant or additional treatment plan, Denvax complements conventional therapies like surgery, radiation, and chemotherapy. By working in conjunction with these treatments, Denvax aims to maximize the effectiveness of prostate cancer treatment.

One of the key advantages of Denvax is its targeted therapy approach. Unlike traditional treatments that can harm healthy cells, Denvax specifically targets cancer cells while sparing healthy tissue.

Moreover, Denvax targets micrometastasis, addressing the disseminated cancer cells responsible for cancer recurrence and relapse post-treatment. By targeting these microscopic cancer cells, Denvax aims to prevent disease progression and improve long-term outcomes for patients.

Safety and effectiveness are paramount with Denvax, offering a well-tolerated treatment option that can help prolong life. By slowing the spread of cancer, preventing relapse, and enhancing overall quality of life, Denvax represents a promising advancement in prostate cancer care.

How Denvax Works in Prostate Cancer Treatment

In prostate cancer, the body’s immune system often fails to recognize cancer cells as threats. This failure stems from various factors, including the inability of immune cells to identify cancer cells or the development of mechanisms by cancer cells to evade detection by the immune system. As a result, tumors may grow unchecked, without encountering a robust immune response.

Dendritic cells play a pivotal role in our immune system’s ability to recognize and combat cancer cells. These specialized immune cells serve as crucial mediators of immune responses by presenting antigens, or foreign substances, to other immune cells. By displaying antigens derived from cancer cells on their surface, dendritic cells effectively “alert” the immune system to the presence of cancerous tissue.

Upon encountering cancer cells, dendritic cells undergo a process of antigen processing, where they break down cancer cell components into smaller fragments or “bits.” These processed antigens are then presented on the surface of dendritic cells, effectively marking the cancer cells for recognition by other immune cells.

Once dendritic cells have processed and presented cancer cell antigens, they initiate a cascade of immune responses aimed at targeting and destroying cancer cells. Activated immune cells, including cytotoxic T cells and natural killer cells, are mobilized to recognize and eliminate cancerous tissue throughout the body.

By jumpstarting the immune response against cancer cells, Denvax therapy harnesses the power of dendritic cells to enhance the body’s ability to fight prostate cancer. This targeted approach aims to overcome the immune system’s failure to recognize cancer cells and stimulate a robust immune attack against tumor tissue.

Through Denvax therapy, the activated immune system becomes a potent force in combating prostate cancer, circulating throughout the body to seek out and destroy cancer cells wherever they may be present. This innovative immunotherapy offers new hope for patients by leveraging the body’s natural defenses to combat this challenging disease.

Final Note

Immunotherapy presents a promising frontier in the battle against prostate cancer. By harnessing the body’s own immune system, treatments like Denvax offer a targeted and personalized approach to fighting cancer cells while minimizing harm to healthy tissues. With ongoing research and clinical trials, the landscape of prostate cancer treatment continues to evolve, offering hope for improved outcomes and better quality of life for patients. 

 

It’s essential for individuals diagnosed with prostate cancer to stay informed about the latest advancements in immunotherapy and work closely with their healthcare team to explore all available treatment options tailored to their specific needs and circumstances. Together, we can continue to make strides in prostate cancer care and bring new hope to those affected by this disease.

What is Targeted Therapy ?

In 2020, approximately 10 million cancer-related fatalities were reported worldwide, making it one of the major causes of…

Comments54

  1. Быстро и просто купить диплом о высшем образовании. Изготовление диплома занимает немного времени, а стоимость – доступна каждому человеку. Таким образом вы имеете возможность сохранить деньги и время и найти работу вашей мечты. Приобрести диплом на заказ возможно через сайт компании. – [url=http://kh.txi.ru/forum/index.php?showtopic=67972/]kh.txi.ru/forum/index.php?showtopic=67972[/url]

  2. займ на карту срочно онлайн москва [url=https://www.vc.ru/rejting/1964646-kredity-na-kartu-na-god-s-plokhoy-istoriey]https://www.vc.ru/rejting/1964646-kredity-na-kartu-na-god-s-plokhoy-istoriey[/url] .

  3. Ukrainian President Volodymyr Zelensky will meet US President Joe Biden and Vice President Kamala Harris in Washington on Thursday. Leon Neal/Getty Images
    CNN

    Ukrainian President Volodymyr Zelensky’s visit to the White House on Thursday could be his final chance to convince a receptive American president of his country’s war aims.
    [url=https://mega555kf7lsmb54yd6etzginolhxxi4ytdoma2rf77ngq55fhfcnyid-at.com]MEGA сайт[/url]
    The precise details of the “victory plan” Zelensky plans to present in separate meetings to President Joe Biden and Vice President Kamala Harris are unknown, having been closely held until they are presented to the American leaders.

    But according to people briefed on its broad contours, the plan reflects the Ukrainian leader’s urgent appeals for more immediate help countering Russia’s invasion. Zelensky is also poised to push for long-term security guarantees that could withstand changes in American leadership ahead of what is widely expected to be a close presidential election between Harris and former President Donald Trump.

    The plan, people familiar with it said, acts as Zelensky’s response to growing war weariness even among his staunchest of western allies. It will make the case that Ukraine can still win — and does not need to cede Russian-seized territory for the fighting to end — if enough assistance is rushed in.

    That includes again asking permission to fire Western provided long-range weapons deeper into Russian territory, a line Biden once was loathe to cross but which he’s recently appeared more open to as he has come under growing pressure to relent.

    Even if Biden decides to allow the long-range fires, it’s unclear whether the change in policy would be announced publicly.

    Biden is usually apt to take his time making decisions about providing Ukraine new capabilities. But with November’s election potentially portending a major change in American approach to the war if Trump were to win, Ukrainian officials — and many American ones — believe there is little time to waste.
    мега сайт
    https://megaweb-12at.com
    Trump has claimed he will be able to “settle” the war upon taking office and has suggested he’ll end US support for Kyiv’s war effort.

    “Those cities are gone, they’re gone, and we continue to give billions of dollars to a man who refused to make a deal, Zelensky. There was no deal that he could have made that wouldn’t have been better than the situation you have right now. You have a country that has been obliterated, not possible to be rebuilt,” Trump said during a campaign speech in Mint Hill, North Carolina, on Wednesday.

    Comments like those have lent new weight to Thursday’s Oval Office talks, according to American and European officials, who have described an imperative to surge assistance to Ukraine while Biden is still in office.

    As part of Zelensky’s visit, the US is expected to announce a major new security package, thought it will likely delay the shipping of the equipment due to inventory shortages, CNN previously reported according to two US officials. On Wednesday, the US announced a package of $375 million.

    The president previewed Zelensky’s visit to the White House a day beforehand, declaring on the margins of the United Nations General Assembly his administration was “determined to ensure that Ukraine has what it needs to prevail in fight for survival.”
    [url=https://megaweb16at.com]megaweb12.com[/url]
    “Tomorrow, I will announce a series of actions to accelerate support for Ukraine’s military – but we know Ukraine’s future victory is about more than what happens on the battlefield, it’s also about what Ukrainians do make the most of a free and independent future, which so many have sacrificed so much for,” he said.

  4. Заказать документ о получении высшего образования можно в нашей компании в столице. Купить диплом ВУЗа по невысокой цене возможно, обратившись к надежной специализированной фирме. [url=http://allnewstroy.ru/kak-byistro-i-bezopasno-kupit-diplom-v-rossii/]allnewstroy.ru/kak-byistro-i-bezopasno-kupit-diplom-v-rossii[/url]

  5. купить диплом ссср о среднем образовании [url=http://orikdok-v-gorode-astrakhan-30.online]купить диплом ссср о среднем образовании[/url] .

  6. купить диплом в пскове [url=www.orikdok-1v-gorode-kurgan-45.online]www.orikdok-1v-gorode-kurgan-45.online[/url] .

  7. Мы можем предложить дипломы любых профессий по разумным ценам. Покупка документа, подтверждающего обучение в ВУЗе, – это грамотное решение. Заказать диплом о высшем образовании: [url=http://meetcloseyou.copiny.com/question/details/id/1093577/]meetcloseyou.copiny.com/question/details/id/1093577[/url]

  8. Вы приобретаете диплом в надежной и проверенной временем компании. Заказать диплом о высшем образовании– [url=http://masterdiplomov.ru/kupit-diplom-s-reestrom-v-moskve-bistro-i-nadezhno-2/]masterdiplomov.ru/kupit-diplom-s-reestrom-v-moskve-bistro-i-nadezhno-2/[/url]

  9. Приобрести диплом университета!
    Наши специалисты предлагаютбыстро и выгодно приобрести диплом, который выполнен на бланке ГОЗНАКа и заверен мокрыми печатями, водяными знаками, подписями официальных лиц. Диплом пройдет лубую проверку, даже с использованием профессионального оборудования. Достигайте свои цели максимально быстро с нашими дипломами- [url=http://businessoutlook.copiny.com/question/details/id/1087610/]businessoutlook.copiny.com/question/details/id/1087610[/url]

  10. Мы предлагаем быстро и выгодно приобрести диплом, который выполнен на оригинальной бумаге и заверен печатями, штампами, подписями официальных лиц. Наш диплом способен пройти любые проверки, даже при использовании специально предназначенного оборудования. [url=http://hellotrek.com/kupit-diplom-bystro-i-nadezhno-luchshie-197-2/]hellotrek.com/kupit-diplom-bystro-i-nadezhno-luchshie-197-2[/url]

  11. 1вин официальное зеркало на сегодня [url=https://1win22010.ru/]https://1win22010.ru/[/url] .

  12. Приобрести диплом о высшем образовании !
    Приобретение диплома ВУЗа России у нас является надежным процессом, ведь документ будет заноситься в государственный реестр. Приобрести диплом любого университета [url=http://fastdiploms.com/pokupka-diploma-s-zaneseniem-v-reestr-legko-i-bistro/]fastdiploms.com/pokupka-diploma-s-zaneseniem-v-reestr-legko-i-bistro[/url]

  13. How Trump changed his mind on tariffs

    +2
    Peter Nicholas, Garrett Haake and Carol E. Lee
    Reporting from Washington
    [url=https://mgmarket-4.at]mgmarket10.at[/url]
    “Liberation Day” gave way to Capitulation Day last night.

    President Donald Trump pulled back yesterday on a series of harsh tariffs targeting friends and foes alike in an audacious bid to remake the global economic order.

    Image: President Donald Trump
    Saul Loeb / AFP – Getty Images
    Trump’s early afternoon announcement followed a harrowing week in which Republican lawmakers and confidants privately warned him that the tariffs could wreck the economy. His own aides had quietly raised alarms about the financial markets before he suspended a tariff regime that he had unveiled with a flourish just one week earlier in a Rose Garden ceremony.
    [url=https://mgmarket10at.com]mgmarket4 at[/url]
    The stock market rose immediately after the about-face, ending days of losses that have forced older Americans who’ve been sinking their savings into 401(k)s to rethink their retirement plans.

    Read the full story here.

    32m ago / 12:55 PM GMT+3
    Sharesocial share icon trigger
    China’s foreign ministry calls the U.S. a ’21st century barbarian’

    Peter Guo

    Reporting from Hong Kong

    China’s public language on its trade war with the U.S. has become increasingly bellicose and took a new turn today when Beijing’s foreign ministry said the Trump administration’s tariffs have made the U.S. a “barbarian of the 21st century.”

    Trump’s tariffs will “never America great again” ministry of foreign affairs spokesperson Huang Jingrui, wrote in an open letter today in Hong Kong’s newspaper South China Morning Post.
    [url=https://mgmarket6at.net]megalinks.at[/url]
    “A tariff-wielding barbarian who attempts to force countries to call and beg for mercy can never expect that call from China,” Huang said, adding that the U.S. is “obsessed with the art of bullying and blackmailing the entire world.”

    47m ago / 12:40 PM GMT+3
    Sharesocial share icon trigger
    EU welcomes 90-day tariff pause

    Peter Guo

    The EU President Ursula von der Leyen said today that the region welcomes Trump’s announcement to pause tariffs for 90 days.

    Von der Leyen said the EU remains “committed to constructive negotiations” with the U.S., according to a statement from her office.

    Meanwhile, Europe continues to focus on diversifying their trade partnerships, engaging with countries that account for 87% of global trade, she said.

    Trump’s tariffs have shown that the European internal market is the region’s “anchor of stability and resilience” in times of uncertainty, von der Leyen added.

    1h ago / 12:27 PM GMT+3
    Sharesocial share icon trigger
    Trade war with China ‘to spark a wave of smuggling’

    Peter Guo

    Reporting from Hong Kong
    [url=https://mgmarket8.net]megalinks at[/url]
    Irregular trade including smuggling will most likely rise amid the U.S.’ and China’s tit-for-tat tariffs, an economist warns.

    The cost of tariffs has become “prohibitive to almost every company,” Tianchen Xu, senior economist at Economist Intelligence Unit.

    “As a result, trade flows in both directions will tumble, and irregular trade will proliferate, including smuggling, transshipment and systemic under-reporting of trade value during customs clearance,” Xu said in a note.

    Xu said trade negotiations and a partial de-escalation in the ongoing trade war may ensue in the coming months, but those tensions are likely to worsen in the short term between the world’s two largest economies.

    1h ago / 12:09 PM GMT+3
    Sharesocial share icon trigger
    California plant business owner says costs will double with tariffs

    Gadi Schwartz and Phil Helsel
    The owner of a California home decor and plant shop said that even in dealing locally, the sourcing of goods from China is impossible to avoid.
    megalinks at

    https://mgmarket6at.net

  14. By Henry Austin
    A Russian-American woman who was imprisoned for treason by Russia has been freed, Secretary of State Marco Rubio said Thursday.
    [url=https://mega2ooyov5nrf42ld7gnbsurg2rgmxn2xkxj5datwzv3qy5pk3p57qd.com]mg11.at[/url]
    Former ballerina Ksenia Karelina was born in Russia but had built a new life as an aesthetician at a Los Angeles spa after immigrating to the United States over a decade ago. She “is on a plane back home to the United States,” having been “wrongfully detained by Russia for over a year,” Rubio said on in a post on X. He credited President Donald Trump with securing her release.
    [url=https://mega2ooyov5nrf42ld7gnbsurg2rgmxn2xkxj5datwzv3qy5pk3p57qd.com]mega2olipdgn3zpmm6fjcl2jfeweyy7gjuzrs3mja7nkchflkdu7lfyd[/url]
    Karolina’s lawyer, Mikhail Mushailov, confirmed her release in a statement on Instagram. “Two hours ago she was in touch with her relatives and took off from Abu Dhabi to the U.S.,” he wrote, adding that he had known about her release since Tuesday.
    [url=https://mega2oakke6o6mya3lte64b4d3mrq2ohz6waamfmszcfjhayszqhchqd.com]mega2oakke6o6mya3lte64b4d3mrq2ohz6waamfmszcfjhayszqhchqd onion[/url]
    Russia’s Federal Security Service (FSB) detained Karelina in January 2024 while she was visiting her parents and young sister in the city Yekaterinburg. It did not provide further details or evidence of her alleged crime.
    [url=https://mega2ooyov5nrf42ld7gnbsurg2rgmxn2xkxj5datwzv3qy5pk3p57qd.com]mega2o2nde2gzktxse2fesqpyfeoma72qmvk3fkecip2l3uv3tbn5mad[/url]
    At the time, Russian legal group Perviy Otdel said it had information that Karelina had donated just over $51.80 from her U.S. bank account on Feb. 24, 2022 — the day that Russia launched its full-scale invasion of Ukraine — to a charity that sends aid to Ukraine. A spa where she had previously worked confirmed this in a statement on Facebook.

    Although Russia’s FSB did not confirm that figure, it said Karelina’s donation “was subsequently used to purchase tactical medical supplies, equipment, weapons, and ammunition for the Ukrainian armed forces.”

    She was sentenced in August to 12 years in a penal colony for “high treason,” having “fully admitted her guilt” at a closed trial in the southwestern Russian city of Yekaterinberg, Sverdlovsky Region Court said in a news release at the time.

    The sentence came against the backdrop of Russia’s 3-year-long war with Ukraine during which President Vladimir Putin’s government has cracked down on dissent. Any perceived criticism of the military is banned.

    Recommended
    megalinks.at

    https://mega2onq5nskz5ib5cg3a2aqkcprqnm3lojxtik2zeou6au6mno7d4ad.com

  15. Заказать диплом о высшем образовании!
    Мы готовы предложить документы учебных заведений, расположенных в любом регионе РФ.
    [url=http://diplomj-irkutsk.ru/kupit-diplom-o-srednem-obrazovanii-bistro-i-nadezhno-4/]diplomj-irkutsk.ru/kupit-diplom-o-srednem-obrazovanii-bistro-i-nadezhno-4/[/url]

  16. Greetings from Uganda!

    I’m Twesige Selegio, Director of Wilma Fox Child Development Centre, a sanctuary for vulnerable children in Uganda. Our centre provides essential services to orphans and disadvantaged children, empowering them with the tools and resources necessary to thrive.

    Our Mission:
    We nurture the physical, emotional, and educational development of our children, enabling them to become confident, capable, and compassionate individuals. Every child deserves a chance to reach their full potential, regardless of their background or circumstances.

    Sponsorship Opportunity:
    We’re reaching out to request sponsorship for a child at just $10/month. Your contribution will directly impact their life, providing:

    1. Education and personal development
    2. Healthcare and nutrition
    3. A safe and nurturing environment

    Make a Difference:
    Your monthly gift of $10 will be a beacon of hope for a child in need. To learn more about our centre and the impact of your donation, please visit our website or contact me directly.

    Donate Now
    You can support us through GlobalGiving: https://www.globalgiving.org/donate/104179/wilma-fox-child-development-centre/

    Get in Touch:
    WhatsApp: +256785521916

    Together, we can make a difference in a child’s life. Thank you for considering this request!

    Sincerely,
    Twesige Selegio
    Director, Wilma Fox Child Development Centre

  17. купить диплом старого образца [url=https://www.orikdok-2v-gorode-vladivostok-25.ru]https://www.orikdok-2v-gorode-vladivostok-25.ru[/url] .

  18. Заказать диплом института по выгодной цене возможно, обращаясь к надежной специализированной компании. Приобрести диплом: [url=http://skrivunder.net/486277/]skrivunder.net/486277[/url]

  19. купить диплом в кемерово [url=https://orikdok-v-gorode-kirov-43.ru/]купить диплом в кемерово[/url] .

  20. купить диплом ссср о среднем образовании [url=https://orikdok-5v-gorode-vladikavkaz-15.online]https://orikdok-5v-gorode-vladikavkaz-15.online[/url] .

  21. купить диплом ссср о среднем образовании [url=http://www.orikdok-5v-gorode-tomsk-70.online]http://www.orikdok-5v-gorode-tomsk-70.online[/url] .

  22. Заказать документ о получении высшего образования вы сможете в нашем сервисе. Купить диплом университета по выгодной стоимости вы можете, обращаясь к проверенной специализированной компании. [url=http://facetom.com/read-blog/4370_mozhno-li-kupit-attestat-9-klassa.html/]facetom.com/read-blog/4370_mozhno-li-kupit-attestat-9-klassa.html[/url]

  23. Приобрести диплом ВУЗа!
    Мы предлагаемвыгодно купить диплом, который выполняется на оригинальной бумаге и заверен печатями, штампами, подписями. Диплом способен пройти любые проверки, даже с применением профессиональных приборов. Достигайте цели максимально быстро с нашими дипломами- [url=http://sparklepools.com.au/kupit-diplom-prostoe-reshenie-dlja-slozhnyh-zadach-116/]sparklepools.com.au/kupit-diplom-prostoe-reshenie-dlja-slozhnyh-zadach-116[/url]

  24. Imagine quitting your job. Reel Cash Vault delivered. Could you? Start Winning Here => u.to/Axk8Ig

  25. Быстро и просто заказать диплом университета!
    Мы изготавливаем дипломы психологов, юристов, экономистов и любых других профессий по доступным ценам— [url=http://studdiplom.ru/]studdiplom.ru[/url]

  26. Лондон один из самых космополитичных городов Европы, в каком месте эскорт-услуги считаются полностью законными и распространенными. Тут оценивают стиль, не плохое образование и умение поддержать разговор эти качества востребованы у эскорт-моделей.

    Правила и законы
    В Великобритании эскорт сам по себе не противоречит закону. Незаконными считаются сутенерство, уличная древнейшая профессия и рекламная инфа интимных услуг. Большая часть эскорт-агентств в Лондоне работают легально, предлагая сопровождение на деловых, светских мероприятиях, музеях или театрах.

    Выбор эскорт агентства
    В столице громадное количество агентств, гарантирующих анонимность, высокий сервис, профессионализм собственных моделей. До бронирования рекомендуется изучить отзывы, познакомиться с условиями сотрудничества и стандартами безопасности [url=https://t.me/london_club_y]escort girls london[/url]

    Этикет и культурные нюансы
    Эскорт в Лондоне это включая наружный вид, а также умение вести себя в обществе. Девушки обязаны быть вежливыми, интеллигентными, разбираться в искусстве, моде, политическом деятеле или бизнесе, чтобы соответствовать статусу клиентов.

  27. [url=https://psee.io/7fxb3x][img]https://tripacostarica.com/1/tr/1.png[/img][/url]
    [b]Summer this year[/b] presents amazing opportunities for budget-conscious travelers looking for unforgettable experiences without depleting the bank.
    To maximize value, think about destinations and strategies that balance affordability with adventure.
    Eastern Europe, like Poland or Hungary, is a gem—vibrant cities like Krakow or Budapest offer rich history, stunning architecture, and delicious cuisine at a segment of Western Europe’s costs.
    [url=https://psee.io/7fxb3x][img]https://tripacostarica.com/1/tr/2.png[/img][/url]
    [b]Hostels and Airbnb[/b] rentals start at $20–$30 per night, and hearty meals cost under $10. Southeast Asia, including Vietnam and Thailand, stays a top selection for tropical vibes.
    Think Hanoi’s bustling markets or Chiang Mai’s serene temples, with street food at $1–$3 and guesthouses around $15.
    [url=https://psee.io/7fxb3x][img]https://tripacostarica.com/1/tr/3.png[/img][/url]
    [b]For North Americans[/b], Mexico’s Riviera Maya mixes pristine beaches with cultural sites like Tulum, where all-inclusive deals start at $80/night.
    Book flights early, use fare alerts, and choose for public transport to save. Traveling off-peak (June or late August) slashes costs further.
    With wise planning, your summer trip can be both affordable and memorable!
    [url=https://psee.io/7fxb3x][b][u]Get your value-for-money travel right now![/u][/b][/url]

  28. профессиональное продвижение сайтов [url=www.prodvizhenie-sajtov-v-moskve233.ru/]профессиональное продвижение сайтов[/url] .

  29. Строительство малоэтажных домов под ключ
    [url=https://ms-stroy.ru/]построить дом в подмосковье[/url]
    Ваш дом – ваши правила:
    выбирайте, как быстро
    хотите заехать
    Вы сами решаете, на каком этапе завершить строительство. Дом можно получить в базовой комплектации, подготовленным к чистовой отделке или укомплектованным к заселению
    Фиксированные сроки строительства и стоимость по договору для любого варианта готовности.
    Ответственность, контроль на всех этапах и проверенные технологии — принципы, которые
    позволили нам создать сотни уютных и надежных домов в Московской, Тверской, Ярославской, Тульской, Владимировской, Калужской области.

  30. Купить диплом о высшем образовании!
    Мы готовы предложить документы ВУЗов, которые расположены в любом регионе России.
    [url=http://diplomt-nsk.ru/kupit-diplom-o-srednem-obrazovanii-bistro-i-nadezhno-5/]diplomt-nsk.ru/kupit-diplom-o-srednem-obrazovanii-bistro-i-nadezhno-5/[/url]

  31. Купить диплом о высшем образовании. Приобретение документа о высшем образовании через качественную и надежную фирму дарит ряд достоинств. Это решение позволяет сберечь как дорогое время, так и существенные финансовые средства. [url=http://orikdok-v-gorode-kirov-43.online/]orikdok-v-gorode-kirov-43.online[/url]

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Book your Consultation with Denvax – Leaders in Immunotherapy!

 

Book your Consultation with Denvax – Leaders in Immunotherapy!